Treatment of chronic idiopathic urticaria unresponsive to type I antihistamines in monotherapy;Traitement de l'urticaire chronique idiopathique resistant aux anti-histaminiques de type 1 en monothérapie

Annales de Dermatologie et de Venereologie

Volumn 130, Issue SPEC. ISS. 1, 2003, Pages

  Mateus, C ^a  

^a Paris Descartes University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CETIRIZINE; CLEMASTINE FUMARATE; CODEINE; COLISTIN; COUMADINE; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DEXCHLORPHENIRAMINE MALEATE; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE THEOPHYLLINATE; DOXEPIN; FLUOXETINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDRALAZINE; HYDROXYZINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; KETOTIFEN; KETOTIFEN FUMARATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MORPHINE; NIFEDIPINE; OXATOMIDE; PENTAMIDINE MESYLATE; PERIACTINE; PETHIDINE; POLYMYXIN; PROMETHAZINE; QUININE; SALAZOSULFAPYRIDINE; SERTRALINE; TERFENADINE; TRANEXAMIC ACID; UNINDEXED DRUG; WARFARIN;

CHRONIC URTICARIA; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CONTROL; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERANCE; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; MEDIATOR; MONOTHERAPY; PATHOGENESIS; PHOTOTHERAPY; PLASMAPHERESIS; PRESCRIPTION; RECURRENT DISEASE; SEDATION; SKIN BLOOD VESSEL; SYMPTOM; TREATMENT FAILURE; TREATMENT INDICATION; ULTRAVIOLET RADIATION;

ADRENERGIC BETA-AGONISTS; ANDROGENS; ANTI-ALLERGIC AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; DRUG RESISTANCE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOTRIENE ANTAGONISTS; PLASMAPHERESIS; ULTRAVIOLET THERAPY; URTICARIA; WARFARIN;

EID: 0037669551     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (110)

1. Kozel MMA, Mekkes JR, Bossuyt PMM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001;45:387-91.
2. Champion RH, Roberts SOB, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969;81:588-97.
3. Claveau J. Histamine-releasing factors in chronic urticaria. Clin Exp Dermatol 2000;25:333-4.
4. Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A, Winkelmann RK, Greaves MW, Barr RM. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996;106:1001.6.
5. Grattan CEH, Sabroe RA, Greaves MW. Chronic urtiacaria. J Am Acad Dermatol 2002;46:645-57.
6. Fox RW. Chronic urticaria: mechanisms and treatment. Allergy Asthma Proc 2001;22:97-100.
7. Fiebiger E. Autoantibodies against the high affinity IgE receptor in chronic idiopathic urticaria. Clin Exp Dermatol 2000;25:333.
8. Elias J, Boss E, Kaplan AP. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986;78:914-8.
9. Negro-Alvarez JM, Carreno-Rojo A, Funes-Vera E, Garcia-Canovas A, Abellan-Aleman AF, Rubio del Barrio R. Pharmacologic therapy for urticaria. Allergol Immunopathol 1997;25:36-51.
10. Castelain M. Urticaires aigües et chroniques: discussion des shémas thérapeutiques. Nouv Dermatol 1994;13:211-30.
11. Tharp MD. Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol 1996;98:S325-30.
12. Doeglas HMG. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975;93:135-44.
13. Goodman DL, McDonnell JT, Nelson HS, Vaughan TR, Weber RW. Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol 1990;86:570-5.
14. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki M. Pseudoallergen-free diet in treatment of chronic urticaria. A prospective study. Acta Derm Venereol (Stockh) 1995;75:484-7.
15. Guida B, De Martino C, De Martino S, Tritto G, Patella V, Trio R, D'Agostino C, Pecoraro P, D'Agostino L. Histamine plasma levels and elimination diet in chronic idiopathic urticaria. Eur J Clin Nutr 2000;54:155-8.
16. Stoneham MD, Young E, Wilkinson JD. Dietary manipulation of fat in chronic urticaria. J Dermatol Treat 1993;4:183-5.
17. Alper BS. Choice of antihistamines for urticaria. Arch Fam Med 2000;9:748-51.
18. Prenner BM. The evolution of pharmacotherapy for rhinitis and urticaria. Allergy Asthma Proc 2001;22:277-80.
19. Lee EE, Maibach HI. Treatment of urticaria. An evidence-based evaluation of antihistamines. Am J Clin Dermatol 2001;2:27-32.
20. Slater JW, Zechnic AD, Haxby DG. Second generation antihistamines. A comparative review. Drugs 1999;57:31-47.
21. Kennard CD, Ellis CN. Pharmacologic therapy for urticaria. J Am Acad Dermatol 1991;25:176-89.
22. Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CTC, Hindley F, Marks R, Hazell M, Rowell NR, Fairiss GM, Cartwright PH, Glenny HP, Howland K. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-center randomized double-blind study. Br J Dermatol 1987;117:81-8.
23. Singh G. H2 blockers in chronic urticaria. Int J Dermatol 1984;23:627-8.
24. Minocha YC, Minocha KB, Sood VK, Dogra A. Evaluation of H2-receptor antagonists in chronic idiopathic urticaria. Ind J Dermatol Venereol Leprol 1995;61:265-7.
25. Estelle F, Simons R. Antihistamine treatment of urticaria. Clin Exp Dermatol 2000;25:339.
26. Harvey rémission partielle, Schocket AL. The effect of H1 and H2 blockade on cutaneous histamine response in man. J Allergy Clin Immunol 1980;65:136-9.
27. Salo OP, Kauppinen K, Mannisto PT. Cimetidine increases the plasma concentration of hydroxyzine. Acta Derm Venereol (Stockh) 1986;66:349-50.
28. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 1995;95:685-93.
29. Phanuphak P, Schocket A, Kohler PF. Treatment of chronic idiopathic urticaria with combined H1 and H2 blockers. Clin Allergy 1978;8:429-33.
30. Kaiser HB, Weisberg SC, Morris RJ. Cimetidine in chronic urticaria. Lancet 1980;26:206.
31. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 1981;117:404-7.
32. Harvey rémission partielle, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981;68:262-6.
33. Paul E, Bödeker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. Eur J Clin Pharmacol 1986;31:277-80.
34. Wozel G, Sahre EM, Barth J. Efficacy of combined therapy of H1 (Tavegyl®) and H2 receptor antagonists (Altramet®) chronic/chronically-recurrent urticaria. Dermatol Monatsschr 1990;176:653-9.
35. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria: a randomized double-blind study. Br J Dermatol 1978;99:675-9.
36. Diller G, Orfanos CE. Managment of idiopathic urticaria with H1+H2 antagonists. A crossover double-blind long-term study. Z Hautkr 1983;58:785-93.
37. Marks R. Treatment of chronic urticaria. Br J Dermatol 1980;102:240.
38. Cook LJ, Shuster S. Lack of effect of cimetidine in chronic idiopathic urticaria. Acta Derm Venereol (Stockh) 1983;63:265-7.
39. Guillot B, Meynadier J. Traitement de l'urticaire chronique par le kétotifène. Allerg Immunol (Paris) 1986;18:33-5.
40. Phanuphak P. Double-blind, placebo-controlled study of ketotifen in chronic urticaria. Immunol Allergy Pract 1987;9:138-43.
41. Kuokkanen K. Comparison of a new antihistamine HC 20-511 with cyproheptadine (periactin) in chronic urticaria. Acta Allergol 1977;32:316-20.
42. Kamide R, Niimura M, Ueda H, Imamura S, Yamamoto S, Yoshida H, Kukita A. Clinical evaluation of ketotifen for chronic urticaria: multicenter double-blind comparative study with clemastine. Ann Allergy 1989;62:322-5.
43. Taskapan O, Harmanyeri Y. Ketotifen and chronic urticaria. Arch Dermatol 1998;134:240-1.
44. Ortolani C, Cornelli U, Bellani M, Pastorello E, Zanussi C. Sodium cromoglycate and provocation tests in chronic urticaria. Ann Allergy 1982;48:50-2.
45. Thormann J, Laurberg G, Zachariae H. Oral sodium cromoglycate in chronic urticaria. Allergy 1980;35:139-41.
46. Pacor ML, Peroli P, Favari F, Lunardi C. Controlled study of oxatomide vs disodium chromoglycate for treating adverse reactions to food. Drugs Exp Clin Res 1992;18:119-23.
47. Kennard CD. Evaluation and treatment of urticaria. In Charlesworth EN, ed Immunology and Allergy Clinics of North America. 1995;15:785-801.
48. Kennes B, De Maubeuge J, Delespesse G. Treatment of chronic urticaria with beta2-adrenergic stimulant. Clin Allergy 1977;7:35-9.
49. Spangler DL, Vanderpool GE, Carroll MS, Tinkelman DG. Terbutaline in the treatment of chronic urticaria. Ann Allergy 1980;45:246-7.
50. Saihan EM. Ketotifen and terbutaline in urticaria. Br J Dermatol 1981;104:205-6.
51. Mestre-Deharo C, Sayag J. Urticaire chronique: place de l'oxatomide. Ann Dermatol Venereol 1990;117 Suppl:10-4.
52. Halpern GM, Levy C, Benveniste P, Levy A. Traitement de l'urticaire chronique par le R35443. Etude clinique, pharmacologique et statistique. Med Hyg 1981;39:120-1.
53. Verhaegen H, De Cree J. Oxatomide in the treatment of idiopathic chronic urticaria. A placebo-controlled study. Allergologie 1980;3:S30-3.
54. Dockx P, Vertommen J, Van Daele R, De Weert J, Amery W. Oxatomide effective in chronic urticaria: a double-blind comparison with placebo. Curr Ther Res 1981;29:510-6.
55. Peremans W, Mertens RLJ, Morias J, Campaert H. Oxatomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial. Dermatologica 1981;162:42-50.
56. Demaubeuge J, Tennstedt D, Broux R. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. Dermatologica 1982;164:386-94.
57. Zabel M, Lindscheid KR. Die behandlung der chronisch rezidivierenden urtikaria mit den H1-antagonisten oxatomid und terfenadin. Therapiewoche 1984;30:4454-8.
58. Beck HI, Cramers M, Herlin T, Sondergaard I, Zachariae H. Comparison of oxatomide and clemastine in the treatment of chronic urticaria. Dermatologica 1985;171:49-51.
59. La Rosa M, Leonardi S, Marchese G, Corrias A, Barberio G, Oggiano N, Grimaldi I. Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. Ann Allergy Asthma Immunol 2001;87:48-53.
60. Figueiredo A, Tellechea O. Calcium channel blocking agents in the treatment of urticaria. Diabetes Care 1986;9:215-6.
61. Liu HN, Pan LM, Hwang SC, Chu TL. Nifedipine for the treatment of chronic urticaria: a double-blind cross-over study. J Dermatol Treat 1990;1:187-9.
62. Lawlor F, Ormerod AD, Greaves MW. Calcium antagonist in treatment of symptomatic dermographism. Low-dose and high-dose studies with nifedipine. Dermatologica 1988;177:287-91.
63. Kalimo K, Jansen CT. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine). Ann Allergy 1980;44:34-7.
64. Bressler RB, Sowell K, Huston DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989;83:756-63.
65. Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS, Drayton G, Indianer L, Peter JB, Barr RJ, Gracey VL. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986;78:867-73.
66. Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985;12:669-75.
67. Harto A, Sendagorta E, Ledo A. Doxepin in treatment of chronic urticaria. Dermatologica 1985;170:90-3.
68. Hashiro M, Yamatodani Y. A combination therapy of psychotropic drugs and antihistaminics or antiallergics in patients with chronic urticaria. J Dermatol Sci 1996;11:209-13.
69. Gupta MA, Gupta AK. Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants? Cutis 1995;56:53-4.
70. Morley WN. Nortriptyline in the treatment of chronic urticaria. Br J Clin Pract 1969;23:305-6.
71. Brestel EP, Thrush BL. The treatment of glucocorticosteroid-dependent chronic urticaria with stanozotol. J Allergy Clin Immunol 1988;82:265-9.
72. Parsad D, Pandhi R, Juneja A. Stanozolol in chronic urticaria: a double-blind, placebo controlled trial. J Dermatol 2001;28:299-302.
73. Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1998;102:876-7.
74. Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000;85:156-7.
75. Spector S. Antileukotrienes in chronic urticaria. J Allergy Clin Immunol 1998;101:572.
76. Asero R, Tedeschi A, Lorini M. Leukotriene receptor antagonists in chronic urticaria. Allergy 2001;56:456-7.
77. Bensch G, Borish L. Leukotriene modifiers in chronic urticaria. Ann Allergy Asthma Immunol 1999;83:348.
78. Pacor M L, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with urticaria and intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001;31:1607-14.
79. Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 2001;137:99-100.
80. Meyer de Schmid JJ, Neuman A. Le traitement de l'urticaire chronique par l'héparine. Bull Soc Franc Dermat Syph 1952;59:286-7.
81. Barlow RJ, Greaves MW. Warfarin in the treatment of chronic urticaria/angio-oedema. Br J Dermatol 1992;126:415-6.
82. Berth-Jones J, Hutchinson PE, Wicks ACB, Mitchell VE. Chronic urticaria with angio-oedema controlled by warfarine. BMJ 1988;297:1382-3.
83. Duvall LA, Boackle RJ, King RG. Warfarin sodium therapy for chronic urticaria and angioedema. South Med J 1986;79:389.
84. Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000;30:1161-5.
85. Tant D. Tranexamic acid in chronic urticaria. Br Med J 1979;1:266.
86. Thompson RA, Felix-Davies DD. Response of idiopathic recurrent angioneurotic oedema to tranexamic acid. Br Med J 1978;2:608.
87. Laurberg G. Tranexamic acid (cyklokapron) in chronic urticaria: a double-blind study. Acta Derm Venerol (stockh) 1977;57:369-70.
88. Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991;88:964-5.
89. Hartmann K, Hani N, Hinrichs R, Hunzelmann N, Scharffetter-Kochanek K. Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria. Acta Derm Venereol 2001;81:71.
90. Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol (Stockh) 1985;65:449-50.
91. Olafsson JH, Larkö O, Roupe G, Granerus G, Bengtsson U. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Arch Dermatol Res 1986;278:288-31.
92. Paradis L, Lavoie A, Brunet C, Bedard PM, Hebert J. Effects of systemic corticosteroids on cutaneous histamine secretion and histamine-releasing factor in patients with chronic idiopathic urticaria. Clin Exp Allergy 1996;26:815-20.
93. Draberova L. Cyclosporin A inhibits rat mast cell activation. Eur J Dermatol 1990;20:1469-73.
94. Fradin MS, Ellis CN, Goldfarb MT, Voorhees JJ. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991;25:1065-7.
95. Barlow RJ, Kobza Black A, Greaves MW. Treatment of severe, chronic urticaria with cyclosporin A. Eur J Dermatol 1993;3:273-5.
96. Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997;52:312-6.
97. Grattan CEH, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza Black A, Greaves MW. Randomized double-blind study of cyclosporin in chronic idiopathic urticaria. Br J Dermatol 2000;143:365-72.
98. Loria MP, Dambra PP, D'Oronzio L, Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacol Immunotoxicol 2001;23:205-13.
99. Gach JE, Sabroe RA, Greaves MW, Kobza Black A. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol 2001;145:340-3.
100. Weiner MJ. Methotrexate in corticosteroid-resistant urticaria. Ann Intern Med 1989;110:848.
101. Stack PS. Methotrexate for urticarial vasculitis. Ann Allergy 1994;72:36-8.
102. Borcea A, Greaves MW. Methotrexate-induced exacerbation of urticarial vasculitis: an usual adverse reaction. Br J Dermatol 2000;143:203-4.
103. Bernstein JA, Garramone SM, Lower EG. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol 2002;89:212-4.
104. Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992;339:1078-80.
105. Kroiss M, Vogt T, Landthaler M, Stolz W. The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria. Acta Derm Venereol 2000;80:225.
106. Asero R. Are IVIG for chronic unremitting urticaria effective? Allergy 2000;55:1099-101.
107. O'donnell BF, Barr RM, Kobza Black A, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101-6.
108. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995;96:901-5.
109. Boehm I, Bauer R, Bieber T. Urticaria treated with dapsone. Allergy 1999;54:765-6.
110. Kelemen J, Gegesi Kiss A, Cserhati E, Mezei G, Puskas J. Immunostimulation therapy of chronic urticaria and angioedema. A pilot double-blind study. Acta Ther 1992;18:81-91.